5F-EDMB-PINACA

From WikiProjectMed
Jump to navigationJump to search
Chemical compound
Pharmaceutical compound
5F-EDMB-PINACA
Clinical data
Other names5-Fluoro EDMB-PINACA
Legal status
Legal status
Identifiers
  • Ethyl (S)-2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate
CAS Number
PubChemCID
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC21H30FN3O3
Molar mass391.487 g·mol−1
3D model (JSmol)
  • O=C(N[C@H](C(OCC)=O)C(C)(C)C)C1=NN(CCCCCF)C2=C1C=CC=C2
  • InChI=1S/C21H30FN3O3/c1-5-28-20(27)18(21(2,3)4)23-19(26)17-15-11-7-8-12-16(15)25(24-17)14-10-6-9-13-22/h7-8,11-12,18H,5-6,9-10,13-14H2,1-4H3,(H,23,26)/t18-/m1/s1
  • Key:VDEACSPMBSUVRD-GOSISDBHSA-N

5F-EDMB-PINACA is adesigner drug andsynthetic cannabinoid.[1][2] In 2018, it was the fourth-most common synthetic cannabinoid identified in drugs seized by theDrug Enforcement Administration.[3]

In the United States, 5F-EDMB-PINACA was temporarily emergency scheduled by the DEA in 2019.[4] It was made a permanentSchedule I Controlled Substance on April 7, 2022.[5]

References

  1. ^Liu C, Jia W, Hua Z, Qian Z (2017). "Identification and analytical characterization of six synthetic cannabinoids NNL-3, 5F-NPB-22-7N , 5F-AKB-48-7N , 5F-EDMB-PINACA, EMB-FUBINACA, and EG-018".Drug Testing and Analysis.9 (8):1251–1261.doi:10.1002/dta.2160.PMID 28063270.
  2. ^"5F-EDMB-PINACA"(PDF). NMS Labs.
  3. ^"Emerging Threat Report: Annual 2018"(PDF). Special Testing and Research Laboratory, Drug Enforcement Administration. Archived fromthe original(PDF) on 2019-08-01. Retrieved2019-08-03.
  4. ^"Schedules of Controlled Substances: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 into Schedule I". Federal Register. 2019-04-16.
  5. ^"Schedules of Controlled Substances: Placement of 5F-EDMB-PINACA, 5FMDMB-PICA, FUB-AKB48, 5F-CUMYLPINACA, and FUB-144 in Schedule I"(PDF).Federal Register.87 (67). 2022-04-07.
Phytocannabinoids
(comparison)
Cannabibutols
Cannabichromenes
Cannabicyclols
Cannabidiols
Cannabielsoins
Cannabigerols
Cannabiphorols
Cannabinols
Cannabitriols
Cannabivarins
Delta-8-tetrahydrocannabinols
Delta-9-tetrahydrocannabinols
Delta-10-Tetrahydrocannabinols
Miscellaneous cannabinoids
Active metabolites
Endocannabinoids
Synthetic
cannabinoid
receptor
agonists /
neocannabinoids
Classical cannabinoids
(dibenzopyrans)
Non-classical
cannabinoids
Adamantoylindoles
Benzimidazoles
Benzoylindoles
Cyclohexylphenols
Eicosanoids
Indazole-3-
carboxamides
Indole-3-carboxamides
Indole-3-carboxylates
Naphthoylindazoles
Naphthoylindoles
Naphthoylpyrroles
Naphthylmethylindenes
Naphthylmethylindoles
Phenylacetylindoles
Pyrazolecarboxamides
Tetramethylcyclo-
propanoylindazoles
Tetramethylcyclo-
propanoylindoles
Others
AllostericCBRTooltip Cannabinoid receptorligands
Endocannabinoid
enhancers
(inactivation inhibitors)
Anticannabinoids
(antagonists/inverse
agonists/antibodies)
Retrieved from "https://mdwiki.org/wiki/5F-EDMB-PINACA"
Categories: